Mukhtar Kulimbet
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mukhtar Kulimbet has a total of 131 co-authors. Here are the top co-authors by number of shared publications:
- Dimash Davletov
Atchabarov Scientific-Research Institute of Fundamental and Applied Medicine, Asfendiyarov Kazakh National Medical University, Almaty 050040, Kazakhstan
4 shared publications - Alisher Makhmutov
Ascension Saint Joseph Hospital, Chicago, IL 60657, USA
3 shared publications - Batyrbek Assembekov
Department of Medicine, S.D. Asfendiyarov Kazakh National Medical University, Almaty 050000, Kazakhstan
3 shared publications - Dinmukhammed Osser
Danbury Hospital/Northwell, Danbury, CT 06810, USA
3 shared publications - Kairat Davletov
Population Health Research Center, Al-Farabi Kazakh National University, Almaty 050012, Kazakhstan
3 shared publications - Marat Pashimov
Research Institute of Cardiology and Internal Diseases, Almaty 050000, Kazakhstan
3 shared publications
Latest Publications
- Open Access
- 13 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (22) , 8908
Digital Cardiac Rehabilitation Following Coronary Revascularization: Effectiveness, Safety, Implementation Barriers and Future Development
Background/Objectives: To critically review the effectiveness, safety and implementation of fully remote, hybrid and digitally supported cardiac rehabilitation (CR) in adults after coronary revascularization by percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG), distinguishing direct from indirect evidence. Methods: This structured narrative review drew on searches of MEDLINE (PubMed), Embase, the Cochrane Library, Scopus and Web of Science, supplemented by reference list and citation searching and by guidance from major cardiology societies. Randomized and non-randomized comparative studies, economic evaluations, qualitative studies and systematic reviews were selected purposively, appraised qualitatively for methodological limitations, and synthesized narratively by outcome, comparator, intervention comprehensiveness and directness of evidence for revascularized patients. Results: Compared with usual care, digital CR improved short-term exercise capacity; compared with center-based CR, it produced broadly similar exercise capacity and short- to intermediate-term quality of life. Lower odds of all-cause readmission with digital CR in one meta-analysis (OR 0.37, 95% CI 0.25–0.56) were based on only seven heterogeneous studies (n = 859) and are not corroborated by the 2023 Cochrane review; effects on major adverse cardiovascular events and mortality remain uncertain. Economic evaluations were generally favorable. Serious exercise-related adverse events were rarely reported in the selected, predominantly lower-risk participants studied, but surveillance was inconsistent, and safety after CABG and in higher-risk patients has not been established. Reimbursement, workforce capacity, interoperability and digital exclusion were the main implementation barriers. Conclusions: Comprehensive remote or hybrid CR is a reasonable option for appropriately assessed, clinically stable, lower-risk patients, particularly after PCI, and a promising way to reach those who would otherwise receive no rehabilitation; patients in the early period after CABG or at higher risk should start with supervised center-based or hybrid care. Digital CR should widen access to multidisciplinary rehabilitation rather than replace supervised programs, and adequately powered trials with long-term clinical and standardized safety outcomes are needed.
- 13 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (22) , 8908
Open AccessDigital Cardiac Rehabilitation Following Coronary Revascularization: Effectiveness, Safety, Implementation Barriers and Future Development
Background/Objectives: To critically review the effectiveness, safety and implementation of fully remote, hybrid and digitally supported cardiac rehabilitation (CR) in adults after coronary revascularization by percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG), distinguishing direct from indirect evidence. Methods: This structured narrative review drew on searches of MEDLINE (PubMed), Embase, the Cochrane Library, Scopus and Web of Science, supplemented by reference list and citation searching and by guidance from major cardiology societies. Randomized and non-randomized comparative studies, economic evaluations, qualitative studies and systematic reviews were selected purposively, appraised qualitatively for methodological limitations, and synthesized narratively by outcome, comparator, intervention comprehensiveness and directness of evidence for revascularized patients. Results: Compared with usual care, digital CR improved short-term exercise capacity; compared with center-based CR, it produced broadly similar exercise capacity and short- to intermediate-term quality of life. Lower odds of all-cause readmission with digital CR in one meta-analysis (OR 0.37, 95% CI 0.25–0.56) were based on only seven heterogeneous studies (n = 859) and are not corroborated by the 2023 Cochrane review; effects on major adverse cardiovascular events and mortality remain uncertain. Economic evaluations were generally favorable. Serious exercise-related adverse events were rarely reported in the selected, predominantly lower-risk participants studied, but surveillance was inconsistent, and safety after CABG and in higher-risk patients has not been established. Reimbursement, workforce capacity, interoperability and digital exclusion were the main implementation barriers. Conclusions: Comprehensive remote or hybrid CR is a reasonable option for appropriately assessed, clinically stable, lower-risk patients, particularly after PCI, and a promising way to reach those who would otherwise receive no rehabilitation; patients in the early period after CABG or at higher risk should start with supervised center-based or hybrid care. Digital CR should widen access to multidisciplinary rehabilitation rather than replace supervised programs, and adequately powered trials with long-term clinical and standardized safety outcomes are needed.
- Open Access
- 22 October 2026
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 23 (11) , 1347
Factors Associated with Low Physical Activity in Patients with Coronary Heart Disease in Kazakhstan: A Multicenter Cross-Sectional Study
Background: Physical activity (PA) is central to the secondary prevention of coronary heart disease (CHD), yet real-world adherence is poor, and data from Central Asia are scarce. Methods: In this cross-sectional study (October 2024–May 2025), 402 patients were recruited 6–24 months after an index coronary event at two Kazakh centers. PA was measured by IPAQ-SF and dichotomized as low versus moderate/high IPAQ-SF category. Multivariable logistic regression identified independent associations with low PA. Results: A total of 152 patients (37.8%) had low PA. Activity was almost exclusively ambulatory: 86.3% reported walking but only 19.9% had any moderate and 11.7% any vigorous activity, and only 29 (7.2%) met WHO/ESC recommendations without counting walking. Low PA was independently associated with recruitment in Aktobe (aOR 3.76, 95% CI 1.98–7.34) and obesity (aOR 1.68, 1.04–2.69); professional exercise advice (aOR 0.45, 0.27–0.73) and the absence of depressive symptoms (aOR 0.42, 0.23–0.76) were associated with lower odds of low PA. Advice was often given but inconsistently followed, and the uptake of fitness clubs (5.6%) and walking groups (10.8%) was minimal. Conclusions: More than one in three patients had low PA, and fewer than one in ten met WHO/ESC recommendations when excluding walking. Depression, obesity, and regional disparity and not conventional risk factors characterized inactive patients.
- 22 October 2026
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 23 (11) , 1347
Open AccessFactors Associated with Low Physical Activity in Patients with Coronary Heart Disease in Kazakhstan: A Multicenter Cross-Sectional Study
Background: Physical activity (PA) is central to the secondary prevention of coronary heart disease (CHD), yet real-world adherence is poor, and data from Central Asia are scarce. Methods: In this cross-sectional study (October 2024–May 2025), 402 patients were recruited 6–24 months after an index coronary event at two Kazakh centers. PA was measured by IPAQ-SF and dichotomized as low versus moderate/high IPAQ-SF category. Multivariable logistic regression identified independent associations with low PA. Results: A total of 152 patients (37.8%) had low PA. Activity was almost exclusively ambulatory: 86.3% reported walking but only 19.9% had any moderate and 11.7% any vigorous activity, and only 29 (7.2%) met WHO/ESC recommendations without counting walking. Low PA was independently associated with recruitment in Aktobe (aOR 3.76, 95% CI 1.98–7.34) and obesity (aOR 1.68, 1.04–2.69); professional exercise advice (aOR 0.45, 0.27–0.73) and the absence of depressive symptoms (aOR 0.42, 0.23–0.76) were associated with lower odds of low PA. Advice was often given but inconsistently followed, and the uptake of fitness clubs (5.6%) and walking groups (10.8%) was minimal. Conclusions: More than one in three patients had low PA, and fewer than one in ten met WHO/ESC recommendations when excluding walking. Depression, obesity, and regional disparity and not conventional risk factors characterized inactive patients.
- Open Access
- 25 August 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (17) , 6548
Determinants of Prolonged Postoperative Length of Stay After Carotid Revascularization: A Single-Center Registry Analysis from Kazakhstan
Background/Objectives: Carotid revascularization reduces stroke risk in patients with carotid stenosis. Postoperative length of stay (LOS) reflects resource utilization and recovery, yet its determinants remain poorly described in Central Asia. This study examined whether baseline patient characteristics predict prolonged postoperative LOS in a Kazakhstani referral cohort. Methods: We analyzed a single-center retrospective cohort (clinical registry) of 320 consecutive patients who underwent carotid revascularization between January 2018 and December 2025. Carotid endarterectomy (CEA) was performed in 88 patients (27.5%) and carotid artery stenting (CAS) in 228 (71.2%). Prolonged postoperative LOS was defined a priori as >8 days (75th percentile). Multivariable logistic regression was performed, with negative binomial regression; a model additionally including procedure type, and a model including in-hospital complications were used as sensitivity analyses. Results: Patients were predominantly male (74.7%) with a mean age of 71.1 ± 7.5 years and a high burden of comorbidities. Median postoperative LOS was 6 days (IQR 4–8), and 72 patients (22.5%) had prolonged LOS. Postoperative LOS was similar after endarterectomy and stenting (median 6 vs 5 days). In-hospital complications occurred in 11 patients (3.4%), with two deaths (0.6%). No baseline characteristic independently predicted prolonged LOS (all p > 0.05; AUC = 0.629; Hosmer–Lemeshow p = 0.45), and procedure type was not associated with prolonged LOS (adjusted OR 1.14, 95% CI 0.61–2.14). In contrast, in-hospital complications were strongly associated with prolonged LOS (adjusted OR 8.50, 95% CI 2.04–35.40; p = 0.003), although this estimate was imprecise owing to the small number of events. Median postoperative LOS increased from 6 days in patients without complications to 12.5 days in those with complications (p < 0.001). Conclusions: In this elderly, comorbidity-heavy cohort, prolonged postoperative LOS was associated with perioperative complications rather than baseline patient characteristics. Because complications lie on the causal pathway between baseline risk and hospital stay, this finding is best interpreted as hypothesis-generating: it suggests that efforts to shorten stay may be better directed toward complication prevention than preoperative risk stratification, a hypothesis that warrants prospective evaluation.
- 25 August 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (17) , 6548
Open AccessDeterminants of Prolonged Postoperative Length of Stay After Carotid Revascularization: A Single-Center Registry Analysis from Kazakhstan
Background/Objectives: Carotid revascularization reduces stroke risk in patients with carotid stenosis. Postoperative length of stay (LOS) reflects resource utilization and recovery, yet its determinants remain poorly described in Central Asia. This study examined whether baseline patient characteristics predict prolonged postoperative LOS in a Kazakhstani referral cohort. Methods: We analyzed a single-center retrospective cohort (clinical registry) of 320 consecutive patients who underwent carotid revascularization between January 2018 and December 2025. Carotid endarterectomy (CEA) was performed in 88 patients (27.5%) and carotid artery stenting (CAS) in 228 (71.2%). Prolonged postoperative LOS was defined a priori as >8 days (75th percentile). Multivariable logistic regression was performed, with negative binomial regression; a model additionally including procedure type, and a model including in-hospital complications were used as sensitivity analyses. Results: Patients were predominantly male (74.7%) with a mean age of 71.1 ± 7.5 years and a high burden of comorbidities. Median postoperative LOS was 6 days (IQR 4–8), and 72 patients (22.5%) had prolonged LOS. Postoperative LOS was similar after endarterectomy and stenting (median 6 vs 5 days). In-hospital complications occurred in 11 patients (3.4%), with two deaths (0.6%). No baseline characteristic independently predicted prolonged LOS (all p > 0.05; AUC = 0.629; Hosmer–Lemeshow p = 0.45), and procedure type was not associated with prolonged LOS (adjusted OR 1.14, 95% CI 0.61–2.14). In contrast, in-hospital complications were strongly associated with prolonged LOS (adjusted OR 8.50, 95% CI 2.04–35.40; p = 0.003), although this estimate was imprecise owing to the small number of events. Median postoperative LOS increased from 6 days in patients without complications to 12.5 days in those with complications (p < 0.001). Conclusions: In this elderly, comorbidity-heavy cohort, prolonged postoperative LOS was associated with perioperative complications rather than baseline patient characteristics. Because complications lie on the causal pathway between baseline risk and hospital stay, this finding is best interpreted as hypothesis-generating: it suggests that efforts to shorten stay may be better directed toward complication prevention than preoperative risk stratification, a hypothesis that warrants prospective evaluation.
- Open Access
- 27 July 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (4) , 439
Prevalence and Determinants of Poor Sleep Quality Among Patients with Established Coronary Heart Disease in Kazakhstan: A Multi-Center Cross-Sectional Study
Background: Poor sleep quality is an increasingly recognized, modifiable cardiovascular risk factor, yet data among patients with established coronary heart disease (CHD) in Central Asia are scarce. We estimated the prevalence of poor sleep quality and identified its correlates in a Kazakhstani CHD population. Methods: In this multi-center cross-sectional study, 398 patients 6–24 months after an index coronary event were assessed for sleep quality. Sleep quality was measured with the Pittsburgh Sleep Quality Index (PSQI; >5 = poor). Anxiety and depression, physical activity, cognition, and clinical and socio-demographic variables were recorded. Associations were examined using logistic regression with subgroup and interaction analyses. Results: Poor sleep quality was reported by 147 patients (36.9%). In the adjusted model, anxiety was the only independent factor associated with poor sleep (OR 1.88, 95% CI: 1.10 to 3.23). The subgroup analysis suggested anxiety (OR 3.94) and lower education (OR 2.58) as correlates in women, whereas retirement (OR 2.27) and low physical activity (OR 2.31) were linked to poor sleep in men. A significant sex–anxiety interaction demonstrated a weaker anxiety effect in men. Conclusions: More than one-third of CHD patients reported poor sleep quality, driven primarily by anxiety, with distinct sex- and age-specific determinants. Sleep and psychological screening should be integrated into secondary prevention, with personalized approaches.
- 27 July 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (4) , 439
Open AccessPrevalence and Determinants of Poor Sleep Quality Among Patients with Established Coronary Heart Disease in Kazakhstan: A Multi-Center Cross-Sectional Study
Background: Poor sleep quality is an increasingly recognized, modifiable cardiovascular risk factor, yet data among patients with established coronary heart disease (CHD) in Central Asia are scarce. We estimated the prevalence of poor sleep quality and identified its correlates in a Kazakhstani CHD population. Methods: In this multi-center cross-sectional study, 398 patients 6–24 months after an index coronary event were assessed for sleep quality. Sleep quality was measured with the Pittsburgh Sleep Quality Index (PSQI; >5 = poor). Anxiety and depression, physical activity, cognition, and clinical and socio-demographic variables were recorded. Associations were examined using logistic regression with subgroup and interaction analyses. Results: Poor sleep quality was reported by 147 patients (36.9%). In the adjusted model, anxiety was the only independent factor associated with poor sleep (OR 1.88, 95% CI: 1.10 to 3.23). The subgroup analysis suggested anxiety (OR 3.94) and lower education (OR 2.58) as correlates in women, whereas retirement (OR 2.27) and low physical activity (OR 2.31) were linked to poor sleep in men. A significant sex–anxiety interaction demonstrated a weaker anxiety effect in men. Conclusions: More than one-third of CHD patients reported poor sleep quality, driven primarily by anxiety, with distinct sex- and age-specific determinants. Sleep and psychological screening should be integrated into secondary prevention, with personalized approaches.
- Open Access
- 20 May 2026
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 23 (5) , 675
Burden of Ischemic Heart Disease in Central Asia from 1990 to 2021: A Systematic Analysis of the Global Burden of Disease Study 2021
Ischemic heart disease (IHD) remains a leading cause of death globally. This study aims to analyze the burden of IHD in Central Asia and in individual countries of the region from 1990 to 2021, through a comparison of trends in incidence, prevalence, mortality, and disability-adjusted life years. Using data from the Global Burden of Disease (GBD) 2021 study, we extracted annual estimates for the Central Asian region, Kazakhstan, Kyrgyzstan, Uzbekistan, Tajikistan, Turkmenistan, Georgia, Armenia, Azerbaijan, and Mongolia. Metrics were reported as age-standardized rates per 100,000 population. Temporal trends were quantified using Average Annual Percent Change based on joinpoint regression models. A stratification by sex and age groups was done. Central Asia consistently maintained a higher IHD burden than the global average. While global age-standardized incidence rates per 100,000 population fell, Central Asia’s rates per 100,000 population rose from 641.97 in 1990 to 801.56 in 2021. Age-standardized death rates per 100,000 population in the region peaked in the mid-1990s following the dissolution of the Soviet Union but decreased overall from 320.47 in 1990 to 265.51 in 2021. However, this remains significantly higher than the 2021 global rate per 100,000 population of 108.73. Uzbekistan exhibited the highest growth in prevalence and incidence rates per 100,000 population, while Georgia demonstrated the largest reduction in DALYs rates per 100,000 population. Men demonstrated a higher burden across most metrics, although the sex gap narrowed in older populations. Central Asia faces rising incidence rates of IHD and burden levels that far exceed global averages. The significant heterogeneity among countries suggests that region-wide generalizations are insufficient and highlights the critical need for targeted, country-specific prevention programs and health system interventions.
- 20 May 2026
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 23 (5) , 675
Open AccessBurden of Ischemic Heart Disease in Central Asia from 1990 to 2021: A Systematic Analysis of the Global Burden of Disease Study 2021
Ischemic heart disease (IHD) remains a leading cause of death globally. This study aims to analyze the burden of IHD in Central Asia and in individual countries of the region from 1990 to 2021, through a comparison of trends in incidence, prevalence, mortality, and disability-adjusted life years. Using data from the Global Burden of Disease (GBD) 2021 study, we extracted annual estimates for the Central Asian region, Kazakhstan, Kyrgyzstan, Uzbekistan, Tajikistan, Turkmenistan, Georgia, Armenia, Azerbaijan, and Mongolia. Metrics were reported as age-standardized rates per 100,000 population. Temporal trends were quantified using Average Annual Percent Change based on joinpoint regression models. A stratification by sex and age groups was done. Central Asia consistently maintained a higher IHD burden than the global average. While global age-standardized incidence rates per 100,000 population fell, Central Asia’s rates per 100,000 population rose from 641.97 in 1990 to 801.56 in 2021. Age-standardized death rates per 100,000 population in the region peaked in the mid-1990s following the dissolution of the Soviet Union but decreased overall from 320.47 in 1990 to 265.51 in 2021. However, this remains significantly higher than the 2021 global rate per 100,000 population of 108.73. Uzbekistan exhibited the highest growth in prevalence and incidence rates per 100,000 population, while Georgia demonstrated the largest reduction in DALYs rates per 100,000 population. Men demonstrated a higher burden across most metrics, although the sex gap narrowed in older populations. Central Asia faces rising incidence rates of IHD and burden levels that far exceed global averages. The significant heterogeneity among countries suggests that region-wide generalizations are insufficient and highlights the critical need for targeted, country-specific prevention programs and health system interventions.
- Open Access
Maternal Outcomes Associated with Delayed Cord Clamping in Hypertensive Disorders of Pregnancy: A Cross-Sectional Study
Background/Objectives: Delayed umbilical cord clamping (DCC) is widely recommended for neonatal benefit; however, concerns persist among professionals that DCC may increase the risk of postpartum hemorrhage. There is a higher risk of postpartum hemorrhage in women with hypertensive disorders of pregnancy (HDP). We aimed to evaluate the association between umbilical cord clamping timing and maternal blood loss in term pregnancies, including those complicated by HDP. Methods: We conducted a cross-sectional study of women delivering at three major hospitals in Almaty, Kazakhstan (August 2020–March 2021). The primary outcome was maternal blood loss. Secondary outcomes included hemoglobin (Hb) and red blood cell (RBC) change from pre-delivery to discharge. Multivariable models were adjusted for maternal age, parity and hypertension category. Results: Two hundred and seven women were analyzed (early cord clamping ≤ 60 (ECC) n = 21; delayed cord clamping 60–119 s (DCC60s) n = 161; delayed cord clamping ≥ 120 s (DCC120s) n = 25). Baseline characteristics were similar across groups except for hypertension distribution. Median blood loss did not differ significantly (255–260 mL; p = 0.9128). Adjusted models confirmed no association between clamping category and blood loss (RoM: ECC vs. DCC60s 0.97; 95% CI 0.93–1.01; DCC120s vs. DCC60s 1.01; 95% CI 0.96–1.07). Conclusions: Among term births in Almaty, including HDP-affected pregnancies, delayed umbilical cord clamping was not associated with increased maternal blood loss or hematologic decline. These findings indicate that DCC does not appear to increase maternal bleeding risk in high-risk obstetric populations and are broadly in line with current international recommendations. Further prospective research is warranted to evaluate specific subgroups, including severe preeclampsia.
Open AccessMaternal Outcomes Associated with Delayed Cord Clamping in Hypertensive Disorders of Pregnancy: A Cross-Sectional Study
Background/Objectives: Delayed umbilical cord clamping (DCC) is widely recommended for neonatal benefit; however, concerns persist among professionals that DCC may increase the risk of postpartum hemorrhage. There is a higher risk of postpartum hemorrhage in women with hypertensive disorders of pregnancy (HDP). We aimed to evaluate the association between umbilical cord clamping timing and maternal blood loss in term pregnancies, including those complicated by HDP. Methods: We conducted a cross-sectional study of women delivering at three major hospitals in Almaty, Kazakhstan (August 2020–March 2021). The primary outcome was maternal blood loss. Secondary outcomes included hemoglobin (Hb) and red blood cell (RBC) change from pre-delivery to discharge. Multivariable models were adjusted for maternal age, parity and hypertension category. Results: Two hundred and seven women were analyzed (early cord clamping ≤ 60 (ECC) n = 21; delayed cord clamping 60–119 s (DCC60s) n = 161; delayed cord clamping ≥ 120 s (DCC120s) n = 25). Baseline characteristics were similar across groups except for hypertension distribution. Median blood loss did not differ significantly (255–260 mL; p = 0.9128). Adjusted models confirmed no association between clamping category and blood loss (RoM: ECC vs. DCC60s 0.97; 95% CI 0.93–1.01; DCC120s vs. DCC60s 1.01; 95% CI 0.96–1.07). Conclusions: Among term births in Almaty, including HDP-affected pregnancies, delayed umbilical cord clamping was not associated with increased maternal blood loss or hematologic decline. These findings indicate that DCC does not appear to increase maternal bleeding risk in high-risk obstetric populations and are broadly in line with current international recommendations. Further prospective research is warranted to evaluate specific subgroups, including severe preeclampsia.
- 1 December 2025
- No. 369,p. 272-281
ESTIMATING THE PREVALENCE OF FAMILIAL HYPERCHOLESTEROLEMIA IN STROKE AND TRANSITORY ISCHEMIC ATTACK POPULATION: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Familial hypercholesterolemia (FH) is a common inherited disorder characterized by lifelong elevation of LDL-cholesterol. While FH prevalence is well described in coronary populations, its contribution to cerebrovascular disease is less clear. This study aims to address this gap by systematically reviewing and synthesizing available evidence to estimate the prevalence of FH in patients with ischemic stroke or transitory ischemic attack overall and across key subgroups. This systematic review included original observational studies, with data on stroke and FH. The protocol was registered in PROSPERO with the ID CRD420251162340. Two reviewers independently screened records, extracted study characteristics and assessed risk of bias. Four studies involving 389272 stroke/transient ischemic attack (TIA) patients (2083 with FH) met eligibility criteria. The pooled prevalence of FH was 0.96% (95% CI 0.11-7.63), with significant between-study heterogeneity (I²=95.3%, τ²=1.7139, p<0.0001). Among patients with large artery atherosclerosis (LAA) strokes, FH prevalence was 2.89% (95% CI 0.05-63.28%), also with highheterogeneity (I²=93.9%, τ²=2.4854, p<0.0001). The evidence linking FH to stroke remains limited and highly heterogeneous, preventing firm quantitative conclusions. However, the available studies offer preliminary signals that FH may have relevance beyond cardiology and should be considered in discussions of cerebrovascular risk. Given the small number of studies and their methodological variability, further research with standardized diagnostic criteria and larger, well-designed cohorts is needed to clarify this relationship and to determine whether improved detection and management of FH in stroke populations could help reduce the broader burden of atherosclerotic disease.
- 1 December 2025
- No. 369,p. 272-281
ESTIMATING THE PREVALENCE OF FAMILIAL HYPERCHOLESTEROLEMIA IN STROKE AND TRANSITORY ISCHEMIC ATTACK POPULATION: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Familial hypercholesterolemia (FH) is a common inherited disorder characterized by lifelong elevation of LDL-cholesterol. While FH prevalence is well described in coronary populations, its contribution to cerebrovascular disease is less clear. This study aims to address this gap by systematically reviewing and synthesizing available evidence to estimate the prevalence of FH in patients with ischemic stroke or transitory ischemic attack overall and across key subgroups. This systematic review included original observational studies, with data on stroke and FH. The protocol was registered in PROSPERO with the ID CRD420251162340. Two reviewers independently screened records, extracted study characteristics and assessed risk of bias. Four studies involving 389272 stroke/transient ischemic attack (TIA) patients (2083 with FH) met eligibility criteria. The pooled prevalence of FH was 0.96% (95% CI 0.11-7.63), with significant between-study heterogeneity (I²=95.3%, τ²=1.7139, p<0.0001). Among patients with large artery atherosclerosis (LAA) strokes, FH prevalence was 2.89% (95% CI 0.05-63.28%), also with highheterogeneity (I²=93.9%, τ²=2.4854, p<0.0001). The evidence linking FH to stroke remains limited and highly heterogeneous, preventing firm quantitative conclusions. However, the available studies offer preliminary signals that FH may have relevance beyond cardiology and should be considered in discussions of cerebrovascular risk. Given the small number of studies and their methodological variability, further research with standardized diagnostic criteria and larger, well-designed cohorts is needed to clarify this relationship and to determine whether improved detection and management of FH in stroke populations could help reduce the broader burden of atherosclerotic disease.
- Open Access
- 19 November 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (22) , 8213
Prevalence of Familial Hypercholesterolemia and Its Association with Cardiovascular Risk in a Cross-Sectional Adult Population
Background/Objectives: Familial hypercholesterolemia (FH) is an inherited lipid disorder that markedly elevates lifetime risk of premature cardiovascular disease (CVD), yet remains under-recognized globally. We aimed to estimate the prevalence of phenotype-defined FH among adults in Almaty, Kazakhstan, describe lipid profiles and treatment patterns, and examine the association between FH status and prevalent CVD. Methods: We conducted a cross-sectional analysis of routinely collected clinical and laboratory data from adults (≥18 years) recorded between March 2023 and March 2024. FH status was classified using Dutch Lipid Clinic Network criteria (probable: 6–8 points; possible: 3–5). Outcomes included lipid measures, statin use, and CVD. Group comparisons used standard tests; multivariable logistic regression estimated adjusted odds ratios (AORs) for prevalent CVD, controlling for age, sex, smoking, body mass index (BMI), systolic blood pressure (SBP), and LDL-C. Results: Among 2468 participants (mean age 45.2 ± 14.3 years; 64.7% women), FH prevalence was 0.4% probable (n = 10) and 6.7% possible (n = 166). FH groups had substantially higher LDL-C and higher systolic blood pressure. Overall statin use was 6.7%; within FH, 13.3% (possible) and 10.0% (probable) used statins. Prevalent CVD affected 18.6% overall, rising to 48.2% (possible FH) and 60.0% (probable FH) (p < 0.001). After adjustment, FH remained independently associated with CVD (AOR 8.15, 95%CI 5.30–12.53 for possible; AOR 40.60, 95%CI 9.15–180.2 for probable vs. non-FH). Age and BMI were positively associated with CVD; LDL-C showed an inverse association consistent with treatment confounding. Conclusions: In this Kazakhstani adult cohort, phenotype-defined FH was present in 0.4% probable and 6.7% possible with a high burden of prevalent CVD and low statin use. These findings highlight substantial missed opportunities for early detection and aggressive lipid-lowering therapy, and support implementing FH identification, treatment intensification, and family-based cascade strategies in Kazakhstan.
- 19 November 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (22) , 8213
Open AccessPrevalence of Familial Hypercholesterolemia and Its Association with Cardiovascular Risk in a Cross-Sectional Adult Population
Background/Objectives: Familial hypercholesterolemia (FH) is an inherited lipid disorder that markedly elevates lifetime risk of premature cardiovascular disease (CVD), yet remains under-recognized globally. We aimed to estimate the prevalence of phenotype-defined FH among adults in Almaty, Kazakhstan, describe lipid profiles and treatment patterns, and examine the association between FH status and prevalent CVD. Methods: We conducted a cross-sectional analysis of routinely collected clinical and laboratory data from adults (≥18 years) recorded between March 2023 and March 2024. FH status was classified using Dutch Lipid Clinic Network criteria (probable: 6–8 points; possible: 3–5). Outcomes included lipid measures, statin use, and CVD. Group comparisons used standard tests; multivariable logistic regression estimated adjusted odds ratios (AORs) for prevalent CVD, controlling for age, sex, smoking, body mass index (BMI), systolic blood pressure (SBP), and LDL-C. Results: Among 2468 participants (mean age 45.2 ± 14.3 years; 64.7% women), FH prevalence was 0.4% probable (n = 10) and 6.7% possible (n = 166). FH groups had substantially higher LDL-C and higher systolic blood pressure. Overall statin use was 6.7%; within FH, 13.3% (possible) and 10.0% (probable) used statins. Prevalent CVD affected 18.6% overall, rising to 48.2% (possible FH) and 60.0% (probable FH) (p < 0.001). After adjustment, FH remained independently associated with CVD (AOR 8.15, 95%CI 5.30–12.53 for possible; AOR 40.60, 95%CI 9.15–180.2 for probable vs. non-FH). Age and BMI were positively associated with CVD; LDL-C showed an inverse association consistent with treatment confounding. Conclusions: In this Kazakhstani adult cohort, phenotype-defined FH was present in 0.4% probable and 6.7% possible with a high burden of prevalent CVD and low statin use. These findings highlight substantial missed opportunities for early detection and aggressive lipid-lowering therapy, and support implementing FH identification, treatment intensification, and family-based cascade strategies in Kazakhstan.
- Open Access
- 6 June 2025
- Published by MDPI AG in Clinics and Practice
- Vol. 15 (6) , 108
Maternal Disorders Associated with Morbidity and Mortality in a Metropolis of Kazakhstan
Background/Objectives: Hypertensive disorders of pregnancy, including pre-eclampsia and eclampsia, are leading causes of maternal morbidity and mortality worldwide and in Kazakhstan. This study aims to assess the burden of hypertensive disorders of pregnancy and main maternal disorders in Almaty, Kazakhstan, using the disability adjusted life years (DALY) methodology. Methods: We conducted a retrospective analysis of women aged 18 and above in Almaty, Kazakhstan, from 2018 to 2020. The medical claim data were retrieved from the Almaty city branch of the Republican Center for Electronic Health Care. Incidence-based DALY were calculated. Results: The total DALY increased for severe pre-eclampsia from 109.3 in 2018 to 187.2 in 2020 per 100,000 population and eclampsia from 3.1 in 2018 to 159.3 in 2020 per 100,000 population. Also, the 25–29 years age group had the largest increase in percent change (5.8) in the total DALY for hypertensive disorders of pregnancy. In addition, the 20–24 years age groups had the largest increase in percent change in the total DALY for severe pre-eclampsia (25.8) and eclampsia (80.5). Conclusions: Our findings highlight an increase in the burden of maternal disorders, especially for severe pre-eclampsia and eclampsia, in Almaty, Kazakhstan, from 2018 to 2020. Younger women bear a significant share of this burden, compounded by the pandemic’s impact on healthcare services.
- 6 June 2025
- Published by MDPI AG in Clinics and Practice
- Vol. 15 (6) , 108
Open AccessMaternal Disorders Associated with Morbidity and Mortality in a Metropolis of Kazakhstan
Background/Objectives: Hypertensive disorders of pregnancy, including pre-eclampsia and eclampsia, are leading causes of maternal morbidity and mortality worldwide and in Kazakhstan. This study aims to assess the burden of hypertensive disorders of pregnancy and main maternal disorders in Almaty, Kazakhstan, using the disability adjusted life years (DALY) methodology. Methods: We conducted a retrospective analysis of women aged 18 and above in Almaty, Kazakhstan, from 2018 to 2020. The medical claim data were retrieved from the Almaty city branch of the Republican Center for Electronic Health Care. Incidence-based DALY were calculated. Results: The total DALY increased for severe pre-eclampsia from 109.3 in 2018 to 187.2 in 2020 per 100,000 population and eclampsia from 3.1 in 2018 to 159.3 in 2020 per 100,000 population. Also, the 25–29 years age group had the largest increase in percent change (5.8) in the total DALY for hypertensive disorders of pregnancy. In addition, the 20–24 years age groups had the largest increase in percent change in the total DALY for severe pre-eclampsia (25.8) and eclampsia (80.5). Conclusions: Our findings highlight an increase in the burden of maternal disorders, especially for severe pre-eclampsia and eclampsia, in Almaty, Kazakhstan, from 2018 to 2020. Younger women bear a significant share of this burden, compounded by the pandemic’s impact on healthcare services.
- Open Access
- 30 April 2025
- Published by Semey Medical University in Наука и здравоохранение
- No. 2(27),p. 15-20
PREDICTORS OF ANTIVIRAL THERAPY INEFFECTIVENESS IN CHRONIC HEPATITIS C: A MATCHED CASE-CONTROL STUDY IN ALMATY, A MAJOR METROPOLIS OF KAZAKHSTAN
This study aims to identify factors contributing to the ineffectiveness of antiviral therapy in patients with chronic hepatitis C (CHC) in Almaty. The rising prevalence and mortality associated with CHC, both in Kazakhstan and globally, underscore the need to improve treatment strategies. Despite the high efficacy of direct-acting antiviral agents (DAAs), some patients fail to achieve a sustained virological response (SVR). This retrospective case-control study included 136 CHC patients treated at healthcare facilities in Almaty, focusing on those who did not attain SVR. Variables such as demographic characteristics, virological status, liver disease stage, comorbidities, lifestyle factors, treatment regimens, and adherence to therapy were analyzed. Logistic regression identified risk factors for non-response to treatment, including comorbid conditions (arterial hypertension, hepatocellular carcinoma) and lifestyle factors. The findings highlight the complexity of CHC treatment in Almaty, emphasizing the importance of personalized approaches that address comorbidities and lifestyle influences. This study contributes to understanding the factors affecting CHC treatment outcomes and supports the optimization of therapeutic strategies in similar healthcare contexts. Целью данного исследования является выявление факторов, способствующих неэффективности противовирусной терапии у пациентов с хроническим гепатитом С (ХГС) в Алматы. Рост распространенности и смертности, связанных с ХГС, как в Казахстане, так и во всем мире, подчеркивает необходимость совершенствования стратегий лечения. Несмотря на высокую эффективность противовирусных препаратов прямого действия (ПППД), у некоторых пациентов не удается достичь устойчивого вирусологического ответа (УВО). Это ретроспективное исследование типа "случай-контроль" включало 136 пациентов с ХГС, проходивших лечение в медицинских учреждениях Алматы, уделяя особое внимание тем, у кого не было достигнуто УВО. Были проанализированы такие переменные, как демографические характеристики, вирусологический статус, стадия заболевания печени, сопутствующие заболевания, факторы образа жизни, схемы лечения и приверженность к терапии. Логистическая регрессия выявила факторы риска отсутствия ответа на лечение, включая сопутствующие заболевания (артериальная гипертензия, гепатоцеллюлярная карцинома) и факторы образа жизни. Полученные данные подчеркивают сложность лечения ХГС в Алматы, подчеркивая важность персонализированных подходов, учитывающих сопутствующие заболевания и влияние образа жизни. Это исследование способствует пониманию факторов, влияющих на результаты лечения ХГС, и помогает оптимизировать терапевтические стратегии в аналогичных медицинских условиях. Бұл зерттеудің мақсаты — Алматы қаласындағы созылмалы С гепатиті (СГС) науқастары арасында вирусқа қарсы терапияның тиімсіздігіне себеп болатын факторларды анықтау. Қазақстанда да, бүкіл әлемде де СГС-ға байланысты аурушаңдық пен өлім-жітімнің өсуі емдеу стратегияларын жетілдіру қажеттігін көрсетеді. Тікелей әсер ететін вирусқа қарсы препараттардың (ТӘВП) жоғары тиімділігіне қарамастан, кейбір науқастар тұрақты вирусологиялық жауапқа (ТВЖ) қол жеткізе алмайды. Бұл зерттеу "жағдай-бақылау" типіндегі ретроспективті талдау болып табылады және Алматыдағы медициналық мекемелерде емделген СГС бар 136 науқасты қамтыды, оның ішінде ТВЖ-қа қол жеткізбеген науқастарға ерекше көңіл бөлінді. Демографиялық көрсеткіштер, вирусологиялық статус, бауыр ауруының сатысы, қосалқы аурулар, өмір салты факторлары, емдеу схемалары және терапияға ұстанымдылық сияқты айнымалылар талданды. Логистикалық регрессия емдеуге жауап бермейтін қауіп факторларын, соның ішінде қатар жүретін ауруларды (артериялық гипертензия, гепатоцеллюлярлық карцинома) және өмір салты факторларын анықтады. Алынған...
- 30 April 2025
- Published by Semey Medical University in Наука и здравоохранение
- No. 2(27),p. 15-20
Open AccessPREDICTORS OF ANTIVIRAL THERAPY INEFFECTIVENESS IN CHRONIC HEPATITIS C: A MATCHED CASE-CONTROL STUDY IN ALMATY, A MAJOR METROPOLIS OF KAZAKHSTAN
This study aims to identify factors contributing to the ineffectiveness of antiviral therapy in patients with chronic hepatitis C (CHC) in Almaty. The rising prevalence and mortality associated with CHC, both in Kazakhstan and globally, underscore the need to improve treatment strategies. Despite the high efficacy of direct-acting antiviral agents (DAAs), some patients fail to achieve a sustained virological response (SVR). This retrospective case-control study included 136 CHC patients treated at healthcare facilities in Almaty, focusing on those who did not attain SVR. Variables such as demographic characteristics, virological status, liver disease stage, comorbidities, lifestyle factors, treatment regimens, and adherence to therapy were analyzed. Logistic regression identified risk factors for non-response to treatment, including comorbid conditions (arterial hypertension, hepatocellular carcinoma) and lifestyle factors. The findings highlight the complexity of CHC treatment in Almaty, emphasizing the importance of personalized approaches that address comorbidities and lifestyle influences. This study contributes to understanding the factors affecting CHC treatment outcomes and supports the optimization of therapeutic strategies in similar healthcare contexts. Целью данного исследования является выявление факторов, способствующих неэффективности противовирусной терапии у пациентов с хроническим гепатитом С (ХГС) в Алматы. Рост распространенности и смертности, связанных с ХГС, как в Казахстане, так и во всем мире, подчеркивает необходимость совершенствования стратегий лечения. Несмотря на высокую эффективность противовирусных препаратов прямого действия (ПППД), у некоторых пациентов не удается достичь устойчивого вирусологического ответа (УВО). Это ретроспективное исследование типа "случай-контроль" включало 136 пациентов с ХГС, проходивших лечение в медицинских учреждениях Алматы, уделяя особое внимание тем, у кого не было достигнуто УВО. Были проанализированы такие переменные, как демографические характеристики, вирусологический статус, стадия заболевания печени, сопутствующие заболевания, факторы образа жизни, схемы лечения и приверженность к терапии. Логистическая регрессия выявила факторы риска отсутствия ответа на лечение, включая сопутствующие заболевания (артериальная гипертензия, гепатоцеллюлярная карцинома) и факторы образа жизни. Полученные данные подчеркивают сложность лечения ХГС в Алматы, подчеркивая важность персонализированных подходов, учитывающих сопутствующие заболевания и влияние образа жизни. Это исследование способствует пониманию факторов, влияющих на результаты лечения ХГС, и помогает оптимизировать терапевтические стратегии в аналогичных медицинских условиях. Бұл зерттеудің мақсаты — Алматы қаласындағы созылмалы С гепатиті (СГС) науқастары арасында вирусқа қарсы терапияның тиімсіздігіне себеп болатын факторларды анықтау. Қазақстанда да, бүкіл әлемде де СГС-ға байланысты аурушаңдық пен өлім-жітімнің өсуі емдеу стратегияларын жетілдіру қажеттігін көрсетеді. Тікелей әсер ететін вирусқа қарсы препараттардың (ТӘВП) жоғары тиімділігіне қарамастан, кейбір науқастар тұрақты вирусологиялық жауапқа (ТВЖ) қол жеткізе алмайды. Бұл зерттеу "жағдай-бақылау" типіндегі ретроспективті талдау болып табылады және Алматыдағы медициналық мекемелерде емделген СГС бар 136 науқасты қамтыды, оның ішінде ТВЖ-қа қол жеткізбеген науқастарға ерекше көңіл бөлінді. Демографиялық көрсеткіштер, вирусологиялық статус, бауыр ауруының сатысы, қосалқы аурулар, өмір салты факторлары, емдеу схемалары және терапияға ұстанымдылық сияқты айнымалылар талданды. Логистикалық регрессия емдеуге жауап бермейтін қауіп факторларын, соның ішінде қатар жүретін ауруларды (артериялық гипертензия, гепатоцеллюлярлық карцинома) және өмір салты факторларын анықтады. Алынған...